CLINICAL AND IMMUNOLOGICAL FEATURES OF THE COURSE AND OUTCOMES OF PNEUMONIA ASSOCIATED WITH CORONAVIRUS INFECTION IN CHILDREN
Keywords:
SARS-CoV-2, Clinical manifestations, COVID-19, Immune PediatricsAbstract
In December 2019, coronavirus disease 2019 (COVID-19), caused by a novel coronavirus (SARS-CoV-2), originated in Wuhan, China, and quickly spread around the world. Little information is available on the clinical features and immunological profile of COVID-19 in pediatrics. The clinical features and treatment outcomes of twelve pediatric patients with a confirmed diagnosis of COVID-19 were analyzed. The immunological characteristics of sick children were studied and compared with twenty adult patients. The median age was 14.5 years (0.64 to 17 years), and six patients were male. The average incubation period was 8 days.
References
Костинов, А. М., Костинов, М. П., & Машилов, К. В. (2020). Пневмококковые вакцины и COVID-19-антагонизм. Медицинский совет, (17), 66-73.
Богвилене, Я. А., Строганова, М. А., Мартынова, Г. П., & Ахметова, В. А. (2021). КЛИНИЧЕСКИЕ ОСОБЕННОСТИ НОВОЙ КОРОНАВИРУСНОЙ ИНФЕКЦИИ COVID-19 У ДЕТЕЙ НА ПРИМЕРЕ Г. КРАСНОЯРСКА. Журнал инфектологии, 13(1 S1), 17-18.
Блох, А. И., Пеньевская, Н. А., Михайлова, О. А., Рудаков, Н. В., Крига, А. С., & Никитин, С. В. (2020). Новая коронавирусная инфекция (COVID-19) среди детского населения Омской области. Журнал инфектологии, 12(4 S1), 37-37.
Савиных, М. В., Калужских, Т. И., Савиных, Н. А., & Егорова, Т. В. (2020). КЛИНИКО-ЭПИДЕМИОЛОГИЧЕСКИЕ АСПЕКТЫ САЛЬМОНЕЛЛЕЗА И КАМПИЛОБАКТЕРИОЗА У ДЕТЕЙ. Журнал инфектологии, 12(4 S1), 97-97.
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Amirova Markhabo Suyunovna
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
All Rights Reserved.
